Every product on this site is supplied strictly for laboratory research use.
You must be 21 or older to enter.
Nothing sold here is intended for human or veterinary consumption, and none of it is
approved by the FDA to diagnose, treat, cure, or prevent any disease.
By entering, you confirm you are 21 or older, that you are a qualified buyer
purchasing for research purposes only, and that you agree to our
Terms & Release of Liability.
You must be 21 or older to access this site. Taking you back.
$65.00Original price was: $65.00.$45.00Current price is: $45.00.
ARA-290, also known as Cibinetide, is a specialized peptide derived from erythropoietin (EPO), engineered to retain its tissue-protective and anti-inflammatory properties without influencing red blood cell production.
ARA-290, also known as Cibinetide, is a specialized peptide derived from erythropoietin (EPO), engineered to retain its tissue-protective and anti-inflammatory properties without influencing red blood cell production. This refined design has positioned ARA-290 as a standout molecule in research focused on nerve repair, inflammation modulation, and tissue protection. This peptide has ideal research in the following categories:
ARA-290 is an 11–amino acid peptide that mimics the protective region of erythropoietin responsible for activating innate repair mechanisms. Unlike full-length EPO, ARA-290 does not stimulate erythropoiesis, allowing researchers to isolate and study its regenerative and protective pathways without hematologic effects.
Mechanism of Action
ARA-290 binds to the innate repair receptor (IRR), a heteromeric receptor involved in tissue protection and inflammation control. Activation of this receptor is believed to reduce pro-inflammatory signaling, support cellular repair processes, and enhance nerve regeneration. Its targeted action provides a clean model for studying tissue resilience and inflammatory balance.
Scientific Interest
Researchers are highly interested in ARA-290 due to its ability to separate EPO’s protective benefits from its erythropoietic activity. This distinction allows for focused investigation into nerve health, chronic inflammation, and tissue-repair pathways without unwanted systemic effects.
Research Focus & Clinical Landscape
Key areas of ongoing and emerging research include:
nerve repair and regeneration
neuropathic signaling and sensitivity pathways
inflammation modulation
tissue protection and cellular resilience
small-fiber nerve research
chronic inflammatory conditions
ARA-290 has been evaluated in both preclinical and clinical research settings, particularly in studies involving neuropathy and inflammatory disorders, and continues to gain traction as a targeted regenerative peptide.
Quality, Craftsmanship & Purity
Our ARA-290 is synthesized in GMP-certified facilities and refined to purity levels exceeding >98%. Each batch undergoes rigorous analytical testing to confirm identity, structural precision, and consistent performance, ensuring reliability for advanced research applications.
Final Insight
ARA-290 represents a refined evolution in tissue-protective peptide research — offering a focused, elegant pathway into nerve repair, inflammation control, and cellular resilience without the complexity of full-length hormone activity.
